Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 2020

View Archived Issues

FDA approves IND to treat COVID-19 patients with stem cells

HMPL-306 enters phase I study for hematological malignancies in China

NP strategy selectively targets brain microvasculature

MPI-8 reduces thrombosis without increased bleeding in vivo

Discovery and preclinical evaluation of novel direct FXIa inhibitor, ONO-1600586

Structural study gives insight into plaque formation

QF-036, a new HIV maturation inhibitor, shows no toxicity in single or repeated dose studies in rats

JAK1 inhibitor CJ-14939 may be a potential adjuvant for NSCLC patients with erlotinib resistance

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Nav1.8 channel blockers

New STING agonists identified at Shanghai Institute of Materia Medica

Breztri Aerosphere approved in U.S. for the maintenance treatment of COPD

Biomea Fusion discovers menin (MEN1)/MLL interaction inhibitors

New mutation in FGB gene found in afibrinogenemia

Beijing Boe Technology Development, Boe Technology Group present EPCAM-targeting agents

Genentech discovers Ire1-alpha inhibitors

FDA allows initiation of clinical trials for desidustat in chemotherapy-induced anemia

Tecartus wins accelerated approval from FDA for relapsed or refractory mantle cell lymphoma

Tumor regression reported in first patients treated with TC-210 in phase I/II study

FDA maintains clinical hold on IGNITE DMD study of SGT-001

Moderna announces phase III study initiation with mRNA-1273 for COVID-19

4D Molecular studies gene therapy 4D-110 in phase I for choroideremia

Fluorine-18 labeling extends half-life of mGluR2 ligand for PET imaging in the brain

Vertex begins phase II trial of VX-864 in PiZZ genotype AAT deficiency

Lung Therapeutics initiates phase II trial of LTI-01 for pleural effusion

Alector begins phase III trial of AL-001 in frontotemporal dementia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...